Finance

Lists
Why is URGN down ၅.၇၆%?
Dive Deeper
URGN:NASDAQ
Urogen Pharma Ltd
၃၄.၅၀ US$
-၅.၇၆%
(-၂.၁၁) 1D
အောက် ၁၆, GMT-၄ ၁၅:၀၆:၄၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
၃၆.၃၅ US$
High
၃၆.၉၁ US$
Low
၃၄.၃၅ US$
Mkt. cap
၁၆၈.၆၄ ဋေ
Avg. vol.
၉.၀၉ သိန်း
Volume
၄.၃၁ သိန်း
52-wk high
၅၀.၈၁ US$
52-wk low
၁၆.၃၆ US$
EPS
-၁.၉၈ US$
Beta
၁.၅၇
Shares outstanding
၄.၈၉ ကုဋေ
No. of employees
၃၀၀
Open
၃၆.၃၅ US$
High
၃၆.၉၁ US$
Low
၃၄.၃၅ US$
Mkt. cap
၁၆၈.၆၄ ဋေ
Avg. vol.
၉.၀၉ သိန်း
Volume
၄.၃၁ သိန်း
52-wk high
၅၀.၈၁ US$
52-wk low
၁၆.၃၆ US$
EPS
-၁.၉၈ US$
Beta
၁.၅၇
Shares outstanding
၄.၈၉ ကုဋေ
No. of employees
၃၀၀
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၅၃ မိနစ်
Nasdaq plunges 2% and these 15 names have led the downward decline
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Walmart (WMT) Adds Premium Wellness Products To More Than 2,300 Stores
CNBC
CNBC
·
ပြီးခဲ့သည့် ၂ နာရီ
Anything not tied to artificial intelligence took off this week
About Urogen Pharma Ltd
CEO-
Employees၃၀၀
Founded၂၀၀၄
Headquartersနယူးယောက်မြို့, နယူးယောက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current ၃၄.၅၀ US$
၇၅.၀၀ US$ (+၁၁၇.၃၉%)
Average
၆၀.၂၀ US$ (+၇၄.၄၉%)
Lowest
၄၈.၀၀ US$ (+၃၉.၁၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၇၅.၀၀ US$
+၁၁၇.၄%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၆၀.၀၀ US$
+၇၃.၉%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
၄၈.၀၀ US$
+၃၉.၁%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
၅၈.၀၀ US$
+၆၈.၁%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
၆၀.၀၀ US$
+၇၃.၉%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
၃၂.၀၀ US$
-၇.၂%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
၄၃.၀၀ US$
+၂၄.၆%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
၄၀.၀၀ US$
+၁၅.၉%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
၄၀.၀၀ US$
+၁၅.၉%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂.၇၅ ကုဋေ
၃.၇၈ ကုဋေ
၅.၁၀ ကုဋေ
၇.၂၅ ကုဋေ
Cost of goods sold
၃.၂၈ သန်း
၃.၂၉ သန်း
၄.၁၄ သန်း
၆.၅၇ သန်း
Cost of revenue
၃.၂၈ သန်း
၃.၂၉ သန်း
၄.၁၄ သန်း
၆.၅၇ သန်း
Research and development expenses
၁.၄၀ ကုဋေ
၁.၄၃ ကုဋေ
၁.၅၆ ကုဋေ
၁.၇၃ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၇၆ ကုဋေ
၃.၉၃ ကုဋေ
၅.၁၅ ကုဋေ
၄.၈၄ ကုဋေ
Operating expense
၅.၁၆ ကုဋေ
၅.၃၇ ကုဋေ
၆.၇၁ ကုဋေ
၆.၅၈ ကုဋေ
Total operating expenses
၅.၄၉ ကုဋေ
၅.၇၀ ကုဋေ
၇.၁၂ ကုဋေ
၇.၂၃ ကုဋေ
Operating income
-၂.၇၄ ကုဋေ
-၁.၉၁ ကုဋေ
-၂.၀၃ ကုဋေ
၁.၁၁ သိန်း
Other non operating income
-၄.၈၂ သန်း
-၄.၆၆ သန်း
-၄.၈၃ သန်း
-၄.၈၉ သန်း
EBT including unusual items
-၃.၄၄ ကုဋေ
-၂.၆၆ ကုဋေ
-၂.၈၃ ကုဋေ
-၈.၇၂ သန်း
EBT excluding unusual items
-၃.၄၄ ကုဋေ
-၂.၆၆ ကုဋေ
-၂.၈၃ ကုဋေ
-၈.၇၂ သန်း
Income tax expense
-၁.၀၅ သန်း
-၂.၇၅ သိန်း
-၄.၇၇ သန်း
၅.၆၃ သန်း
Effective tax rate
၃.၀၆%
၁.၀၃%
၁၆.၈၃%
-၆၄.၅၄%
Other operating expenses
-
-
-
-
Net income
-၃.၃၃ ကုဋေ
-၂.၆၄ ကုဋေ
-၂.၃၆ ကုဋေ
-၁.၄၄ ကုဋေ
Net profit margin
-၁၂၁.၃၄%
-၆၉.၆၈%
-၄၆.၂၆%
-၁၉.၈၁%
Earnings per share
-၀.၆၉
-၀.၅၃
-၀.၄၇
-၀.၂၈
Interest and investment income
၁.၁၈ သန်း
၉.၀၈ သိန်း
၉.၃၁ သိန်း
၉.၄၆ သိန်း
Interest expense
-၃.၃၇ သန်း
-၃.၇၇ သန်း
-၄.၁၈ သန်း
-၄.၈၉ သန်း
Net interest expenses
-၂.၂၀ သန်း
-၂.၈၆ သန်း
-၃.၂၅ သန်း
-၃.၉၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၇၃ ကုဋေ
-၁.၉၀ ကုဋေ
-၂.၀၂ ကုဋေ
၁.၈၉ သိန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ